[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
[ Fri, Dec 10th 2021 ]: WOPRAI
Shagun Singh Initiated (BSX) at Buy and Held Target at $51 on, Dec 10th, 2021
- 🞛 This publication is a summary or evaluation of another publication
Shagun Singh of RBC Capital, Initiated "Boston Scientific Corporation" (BSX) at Buy and Held Target at $51 on, Dec 10th, 2021.
Shagun has made no other calls on BSX in the last 4 months.
There is 1 other peer that has a rating on BSX. Out of the 1 peers that are also analyzing BSX, 0 agree with Shagun's Rating of Hold.
This is the rating of the analyst that currently disagrees with Shagun
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Decreased Target to $51 on, Thursday, October 28th, 2021